Big Gaps In Vaccination Supplies Highlighted In Whistleblower Complaint; Will RAPID Partnership Save The Day?
Ousted BARDA chief says HHS leaders ignored his warnings that the US lacks the necessary supplies of needles and syringes to administer a widespread COVID-19 vaccination campaign, and it could take the country two years to have enough supplies. A new public-private partnership announced in March is working to fill in those gaps.
You may also be interested in...
Coronavirus Notebook: Remdesivir Supply Dwindles; US FDA Signs Another RWE Deal; Corning Gets BARDA Contract For Glass Vials
Dispatches from a world turned upside down also include changes in drug sample distribution guidelines and further reductions in the hours of FDA’s COVID hotline.
FDA’s Peter Marks and Janet Woodcock will be on the bridge for Operation Warp Speed; Moncef Slaoui says early clinical data on one vaccine candidate makes him confident that a few hundred million doses of a vaccine can be available by the end of the year.
At Senate hearing, FDA and NIH officials say government and vaccine developers are outlining production needs with ability to shift manufacturing from their candidates to others to ensure production of the most promising products. FDA Commissioner Hahn says as an essential worker he would break quarantine if needed at a critical White House or other meeting.